Regulations.gov document
Attachment 11 "21 CFR 170.35 (c) (1) (i) Description of the Substance (e) Structural…
Supporting & Related Material · FDA-1985-G-0292 · posted Aug 3, 2016
Key facts
| Document ID | FDA-1985-G-0292-0007 |
|---|---|
| Title | Attachment 11 "21 CFR 170.35 (c) (1) (i) Description of the Substance (e) Structural Formula" Novo Laboratories, Inc.; Filing of Petition for Affirmation for GRAS Status from Novo Laboratories, Inc.; |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-1985-G-0292 |
| Posted | Aug 3, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: